Your Messages Inbox
Your Article Summary
See Latest ArticlesNew AcrySof(R) IQ Toric IOL Approved for U.S. Patients with Cataracts and Astigmatism
Alcon, 03/03/09
Alcon, Inc., the world's leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration approved its aspheric AcrySof IQ Toric intraocular lens. The new lens offers an enhanced aspheric optic that improves image quality and increases contrast sensitivity in cataract surgery patients with astigmatism. The innovative lens design offers these patients the best opportunity for quality distance vision without glasses.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis gains rights to two oral targeted investigational therapies focusing on patients with life-threatening blood disorders and cancers
Novartis, 11/30/09
Major European regulatory milestone in cardiovascular protection for Micardis : Now approved by the European Commission to reduce the risk of cardiovascular (CV) morbidity in high CV risk patients
Boehringer Ingelheim, 11/30/09
Human genome sciences submits biologics license application to fda for zalbin
Human Genome Sciences, 11/30/09
Article Search
Sponsor